Interní Med. 2011; 13(1): 28-30
The continuously increasing number of obese people in both the developed and developing world represents a growing health, social
and economic burden in the individual countries. Obesity accounts for 2–8 % of health care costs and 10–13 % of deaths in Europe. Virtually
all physicians must be prepared to fight obesity because obese individuals will represent an increasingly larger proportion of their
patients. Given the limited pharmacotherapy options, more attention is paid to the surgical treatment of obesity and the use of very
low calorie diets (VLCDs). A new group of anti-diabetic drugs base on incretin principle with a positively inpact no weight reduction are
discussed. The paper provides brief instructions on how to approach obese patients, how to examine and treat them.
Published: January 14, 2011 Show citation